DEL BOCCIO, PIERO
 Distribuzione geografica
Continente #
EU - Europa 2.926
NA - Nord America 2.816
AS - Asia 986
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 4
AF - Africa 3
Totale 6.755
Nazione #
US - Stati Uniti d'America 2.805
IT - Italia 759
IE - Irlanda 602
CN - Cina 479
SE - Svezia 366
UA - Ucraina 343
GB - Regno Unito 296
TR - Turchia 277
FR - Francia 159
DE - Germania 137
IN - India 98
SG - Singapore 83
RU - Federazione Russa 81
FI - Finlandia 79
CZ - Repubblica Ceca 34
BE - Belgio 23
VN - Vietnam 22
PL - Polonia 20
AU - Australia 12
AE - Emirati Arabi Uniti 8
CA - Canada 7
NL - Olanda 7
AT - Austria 5
EU - Europa 4
HK - Hong Kong 4
KR - Corea 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
GR - Grecia 3
IR - Iran 3
MX - Messico 3
CL - Cile 2
ES - Italia 2
IL - Israele 2
PK - Pakistan 2
ZA - Sudafrica 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
JP - Giappone 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.755
Città #
Chandler 672
Dublin 594
Jacksonville 426
Chieti 220
Southend 216
Princeton 199
Izmir 153
Nanjing 143
Dearborn 138
Ashburn 137
Ann Arbor 89
Altamura 88
Beijing 88
Wilmington 88
Boardman 76
Cambridge 64
New York 60
Nanchang 57
Singapore 51
Woodbridge 43
Rome 36
Kunming 27
Shenyang 24
Brno 22
Brussels 22
Dong Ket 22
Helsinki 20
Munich 20
Hangzhou 19
Hebei 18
San Mateo 18
Pescara 17
Tianjin 17
Washington 17
Los Angeles 16
Jiaxing 15
Kraków 15
Seattle 15
Augusta 14
Guangzhou 13
L'aquila 13
Grevenbroich 11
Norwalk 11
Jinan 10
Olomouc 10
Teramo 10
Redwood City 9
Changsha 8
London 8
Pune 8
Sydney 8
Falls Church 7
Leawood 7
Milan 7
Roseto Degli Abruzzi 7
Auburn Hills 6
Bologna 6
Houston 6
Bangalore 5
Edinburgh 5
Hanover 5
La Spezia 5
L’Aquila 5
San Vito Chietino 5
Vienna 5
Aquila 4
Brescia 4
Dubai 4
Hong Kong 4
Lanzhou 4
Lappeenranta 4
Naples 4
Orange 4
Pianella 4
San Giovanni 4
Sant'elpidio A Mare 4
Toronto 4
Viterbo 4
Zhengzhou 4
Alba 3
Ameno 3
Amsterdam 3
Ardabil 3
Bialystok 3
Bitritto 3
Carpi 3
Changchun 3
Chicago 3
Glasgow 3
Hefei 3
Lequile 3
Moscow 3
Ningbo 3
Padova 3
Sulmona 3
Tatura 3
Verona 3
Acerra 2
Ancona 2
Birmingham 2
Totale 4.292
Nome #
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 135
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 128
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 124
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 119
Visible Photostability of Ruthenium and Platinum Phthalocyanines in Water and in the presence of Organic Substrates 105
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 105
Serum Lipidomic study reveals potential early biomarkers for predicting response to chemoradiotherapy in advanced rectal cancer: A pilot study 104
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 101
Cleavage of cystatin C is not associated with multiple sclerosis 100
Proteomics characterization of protein adsorption onto hemodialysis membranes 99
A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis. 98
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action 97
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 97
Advances in Lipidomics for Cancer Biomarkers Discovery 96
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage 96
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 94
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 91
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes 91
Proteomic profiling of coronary thrombus in acute myocardial infarction 90
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 89
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 87
Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics 86
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 85
Proteomics of thyroid fine-needle apiration: a promising approach for protein biomarker discovery 84
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. 83
ESI-MS in the study of the activity of alpha-chymotrypsin in aqueous surfactant media. 83
LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise 83
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 83
Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry 83
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 82
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 82
Stereoselective double reduction of 3-methyl-2-cyclohexenone by use of palladium and platinum nanoparticles in tandem with alcohol dehydrogenase 82
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. 81
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. 81
AFFINITY AND SPECIFICITY OF ANTI-GM1 ANTIBODIES IN THE EXPERIMENTAL AXONAL MODEL OF GUILLAIN-BARRE SYNDROME 81
Homo sapiens proteomics: clinical perspectives 78
Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. 78
Protein expression profiling of Proteus mirabilis under chemical stress condition: A proteomic investigation without genome 78
Lo sviluppo di un confronto matematico per analisi differenziali di proteomica: applicazione ai profili MALDI-TOF-MS lineare. 77
Characterization of oxidation end product of plasma albumin 'in vivo'. 77
Neurodegenerative diseases as proteinopathies-driven immune disorders 77
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 76
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. 75
A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. 74
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. 74
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 74
Glutathione transferases from Anguilla anguilla liver: identification, cloning and functional characterization. 73
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. 73
An Italian Innovative Small-Scale Approach to Promote the Conscious Consumption of Healthy Food 73
Quantitative analysis of caffeic acid phenethyl ester in crude propolis by liquid chromatography-electrospray ionization mass spectrometry. 72
Repetitive Fragmentation Products of Albumin and {alpha}1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome. 72
Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy. 72
Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma 71
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 70
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 70
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. 70
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 70
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 70
DIFFERENTIAL CEREBRO SPINAL FLUID PROTEOME INVESTIGATION OF LEBER HEREDITARY OPTIC NEUROPATHY (LHON) AND MULTIPLE SCLEROSIS. 69
Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations. 69
Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy 69
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 69
Proteomic analysis of protein adsorption onto haemodialysis membranes 68
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 67
A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. 66
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 65
Improving protein identification from linear MALDI-TOF spectra: validation of an automated tool for signal denoising and peak identification 64
Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery 64
extracellular vescicles as signaling mediators and disease biomarkers across biological barriers 63
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 59
High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma. 58
Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms 56
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 55
Cytotoxic and genotoxic effects of composite resins on cultured human gingival fibroblasts 55
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 54
Biomarker investigations in neurodegenerative diseases 53
Sera mass spectrometry investigation in multiple sclerosis-affected patients 51
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples 50
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism 47
Circulating extracellular vesicles as new inflammation marker in hiv infection 44
Identification of an elongation factor 1Bγ protein with glutathione transferase activity in both yeast and mycelial morphologies from human pathogenic Blastoschizomyces capitatus 43
In vitro and in vivo lipidomics as a tool for probiotics evaluation 41
Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy 41
Validation of the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination 40
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 38
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 37
Proteomics Approach Highlights Early Changes in Human Fibroblasts-Pancreatic Ductal Adenocarcinoma Cells Crosstalk 37
Ozone effect on the inflammatory and proteomic profile of human macrophages and airway epithelial cells 35
Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients 35
Analytical Evaluation of the Ideal Strategy for High-Throughput Flow Injection Analysis by Tandem Mass Spectrometry in Routine Newborn Screening 35
Breast cancer in the era of integrating "Omics" approaches 35
Ozone effect on inflammatory and proteomic profile of human macrophages and airway epithelial cells 34
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line 33
Picture of the Favourable Immune Profile Induced by Anti-SARS-CoV-2 Vaccination 33
Fast LC–MS/MS screening method for the evaluation of drugs, illicit drugs, and other compounds in biological matrices 33
Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis 32
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 32
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 32
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 32
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 29
Totale 7.021
Categoria #
all - tutte 27.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020879 0 74 10 31 82 88 166 97 62 115 119 35
2020/2021717 86 14 97 28 53 127 24 15 109 69 40 55
2021/2022538 6 12 11 88 29 21 12 34 83 30 58 154
2022/20231.874 136 268 117 208 206 352 100 129 240 31 54 33
2023/20241.072 69 56 71 34 42 404 180 45 17 19 6 129
2024/2025172 136 36 0 0 0 0 0 0 0 0 0 0
Totale 7.259